XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Jan. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of allocation of stock-based compensation
Pre-tax share-based compensation was included in the Statements of Income for fiscal years 2022, 2021 and 2020 as follows: 
Fiscal Year Ended
(in thousands)January 30, 2022January 31, 2021January 26, 2020
Cost of sales$2,901 $2,501 $1,928 
Selling, general and administrative32,578 37,000 38,556 
Product development and engineering15,710 13,485 11,565 
Share-based compensation$51,189 $52,986 $52,049 
Summary of fair value assumptions
Fiscal Year Ended
(in thousands)January 30, 2022January 31, 2021January 26, 2020
Cost of sales$2,901 $2,501 $1,928 
Selling, general and administrative32,578 37,000 38,556 
Product development and engineering15,710 13,485 11,565 
Share-based compensation$51,189 $52,986 $52,049 
Summary of the activity for stock option awards
The following table summarizes the activity for stock options for fiscal year 2022:
(in thousands, except per share data)Number
of
Shares		Weighted-
Average
Exercise
Price
(per share)
Aggregate
Intrinsic
Value (1)
Number of
Shares
Exercisable		Weighted-Average
Contractual
Term (years)
Vested and expected to vest at January 31, 2021335 $30.28 $13,627 238
Exercised(213)24.73 10,234 
Forfeited(4)35.42 
Vested and expected to vest at January 30, 2022118 $40.17 $3,253 842.4
Vested and exercisable at January 30, 202284 $37.16 $2,579 2.3
(1) The aggregate intrinsic value of stock options vested and exercisable and vested and expected to vest as of January 30, 2022 is calculated based on the difference between the exercise price and the $67.83 closing price of the Company's common stock as of January 30, 2022.
Summary of unvested stock option awards
The following table summarizes information regarding nonvested stock option awards at January 30, 2022:
(in thousands, except per share data)Number
of
Shares		Weighted-Average
Exercise Price
(per share)		Weighted-Average
Grant Date
Fair Value
(per share)
Nonvested at January 31, 202196 $44.80 $13.35 
Vested(61)43.21 12.76 
Forfeited(1)45.13 13.36 
Nonvested at January 30, 202234 $47.73 $14.45 
Summary of activity for market performance units
The following table summarizes the activity for the non-employee directors restricted stock units for the fiscal year ended January 30, 2022:
(in thousands, except per share data)Total
Units		Units Subject to
Share Settlement		Units Subject to
Cash Settlement		Weighted-Average
Grant Date Fair Value
(per share)
Nonvested at January 31, 202128 13 15 $51.52 
Granted24 12 12 68.06 
Vested(28)(13)(15)51.52 
Nonvested at January 30, 202224 12 12 $68.06 
Summary of the status of non-vested restricted stock unit awards and changes during the year
The following table is a summary of the status of nonvested restricted stock unit awards as of January 30, 2022, and changes during the year.
Restricted Stock Units, Stock Grants and
Stock Units
(in thousands, except per share data)
SharesWeighted-Average
Grant Date Fair Value
(per share)
Nonvested at January 31, 20212,059 $50.39 
Granted755 67.91 
Vested(805)47.30 
Forfeited(107)53.63 
Nonvested at January 30, 20221,902 $58.47